Thymus-derived regulatory T cells restrain pro-inflammatory Th1 responses by downregulating CD70 on dendritic cells

The EMBO Journal
Maxime DhainautMuriel Moser

Abstract

The severity and intensity of autoimmune disease in immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) patients and in scurfy mice emphasize the critical role played by thymus-derived regulatory T cells (tTregs) in maintaining peripheral immune tolerance. However, although tTregs are critical to prevent lethal autoimmunity and excessive inflammatory responses, their suppressive mechanism remains elusive. Here, we demonstrate that tTregs selectively inhibit CD27/CD70-dependent Th1 priming, while leaving the IL-12-dependent pathway unaffected. Immunized mice depleted of tTregs showed an increased response of IFN-γ-secreting CD4(+) T cells that was strictly reliant on a functional CD27/CD70 pathway. In vitro studies revealed that tTregs downregulate CD70 from the plasma membrane of dendritic cells (DCs) in a CD27-dependent manner. CD70 downregulation required contact between Tregs and DCs and resulted in endocytosis of CD27 and CD70 into the DC. These findings reveal a novel mechanism by which tTregs can maintain tolerance or prevent excessive, proinflammatory Th1 responses.

References

Jun 10, 1998·International Immunology·H OshimaK Okumura
Feb 2, 1999·The Journal of Experimental Medicine·R Maldonado-LópezM Moser
Oct 10, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·R Maldonado-LópezM Moser
Oct 24, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·B PulendranJ Banchereau
Oct 9, 2002·Nature Immunology·Ursula GrohmannPaolo Puccetti
Dec 24, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Kiki TesselaarRené A W van Lier
Aug 28, 2003·Nature Immunology·Etienne Joly, Denis Hudrisier
Nov 2, 2004·Nature Immunology·Stéphanie HuguesSebastian Amigorena
Sep 20, 2005·Immunity·Simon C Watkins, Russell D Salter
Nov 29, 2005·Nature Immunology·Qizhi TangJeffrey A Bluestone
Mar 15, 2006·The Journal of Experimental Medicine·Carlos E TadokoroMichael L Dustin
Mar 15, 2006·The Journal of Experimental Medicine·Isabelle J SuffiaYasmine Belkaid
Aug 23, 2006·The Journal of Experimental Medicine·Matthias MatterAdrian F Ochsenbein
Jan 4, 2007·The Journal of Experimental Medicine·Katharina LahlTim Sparwasser
Mar 29, 2007·Proceedings of the National Academy of Sciences of the United States of America·Anna M KellerJannie Borst
May 16, 2007·The Journal of Experimental Medicine·Tobias BoppEdgar Schmitt
Jun 6, 2007·International Immunology·Michiel F van OosterwijkRené A W van Lier
Sep 18, 2007·Immunity·Rafal PacholczykLeszek Ignatowicz
Sep 20, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Martin GirouxClaude Perreault
Nov 23, 2007·Nature·Lauren W CollisonDario A A Vignali
Jul 9, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Yanling XiaoJannie Borst
Jul 19, 2008·Proceedings of the National Academy of Sciences of the United States of America·Yasushi OnishiShimon Sakaguchi
Oct 11, 2008·Science·Kajsa WingShimon Sakaguchi
Jun 16, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Monika ManochaN Manjunath
Aug 28, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ezogelin OflazogluIqbal S Grewal
Oct 3, 2009·Science·Ashutosh ChaudhryAlexander Y Rudensky
Feb 9, 2010·Immunity·Alexandre BoissonnasSebastian Amigorena
Mar 10, 2010·Proceedings of the National Academy of Sciences of the United States of America·Anne ChauveauDaniel M Davis

❮ Previous
Next ❯

Citations

Jan 19, 2016·Trends in Immunology·Erik EllwardtFrauke Zipp
Mar 5, 2016·Journal of Cellular and Molecular Medicine·Verena Moosbrugger-MartinzSandrine Dubrac
Apr 28, 2016·Pharmacology & Therapeutics·Jose R Conejo-GarciaJuan R Cubillos-Ruiz
Nov 26, 2015·Journal of Immunology Research·Julie JacobsVanessa Deschoolmeester
Sep 20, 2016·The Journal of Clinical Investigation·Willem S LexmondEdda Fiebiger
Apr 28, 2018·Immunology·Tomasz Ahrends, Jannie Borst
Apr 15, 2015·The EMBO Journal·Lukasz Wojciech, Leszek Ignatowicz
May 19, 2020·British Journal of Haematology·Xian ZhangRenchi Yang
Jul 16, 2020·Communications Biology·Rebeca Arroyo HorneroJoanna Hester
Jun 3, 2021·Cells·Kensuke Miyake, Hajime Karasuyama
Aug 24, 2021·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Sabine MuthHans Christian Probst
Aug 31, 2021·Allergology International : Official Journal of the Japanese Society of Allergology·Keisuke Okamoto, Tomohiro Morio

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Polyendocrine Syndromes

This feed focuses on a rare genetic condition called Autoimmune Polyendocrine Syndromes, which are characterized by autoantibodies against multiple endocrine organs. This can lead to Type I Diabetes.

Autoimmune Polyendocrinopathies

Autoimmune polyendocrinopathies, also called polyglandular autoimmune syndromes (PGASs), or polyendocrine autoimmune syndromes(PASs), are a heterogeneous group of rare diseases characterized by autoimmune activity against more than one endocrine organ, although non-endocrine organs can be affected. Discover the latest research on autoimmune polyendocrinopathies here.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.